Pathwork Diagnostics Tissue of Origin Test Cost-Effective for Increasing Cancer Patient Survival  
1/9/2012 7:41:23 AM

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Pathwork Diagnostics, Inc., a pioneer in creating genomics-based diagnostics in oncology utilizing their proprietary informatics platform, announced today that results from a study involving its Pathwork® Tissue of Origin Test will be presented this week at the American Association for Cancer Research (AACR) - International Association for the Study of Lung Cancer (IASLC) Joint Conference on The Molecular Origins of Lung Cancer: Biology, Therapy and Personalized Medicine (January 8-11, 2012, San Diego).